Recent Patents on Anti-Cancer Drug Discovery
ISSN:1574-8928

Recent Patents on Anti-Cancer Drug Discovery

RECENT PAT ANTI-CANC
学科领域:医学
是否预警:不在预警名单内
是否OA:
录用周期:约3.0个月
新锐分区:医学3区
年发文量:97
影响因子:4.1
JCR分区:Q1

基本信息

最近关于抗癌药物发现的专利发表评论和研究文章,其反映或处理与专利有关的研究、研究中报告的专利的应用、关于给定专利的应用的结果比较的讨论等,此外,还客座编辑了抗癌药物发现领域最新专利的主题问题,例如新的生物活性化合物、类似物、靶点、预测性生物标志物和药效生物标志物。该杂志还出版电子书和抗癌药物发现书籍的书评。该杂志还收录了一些重要的和最近的抗癌药物发现专利。该杂志是所有参与抗癌药物设计和发现的研究人员的必备阅读。该杂志还涵盖了与抗癌药物发现相关的快速新兴治疗领域/靶点和治疗剂的最新研究(已注册专利)。
1574-8928SCIE/Scopus收录
4.1
2.3
2026年3月发布
点击查看历史分区趋势    >
大类学科小类学科Top期刊综述期刊
医学3区
ONCOLOGY 肿瘤学
3区
PHARMACOLOGY & PHARMACY 药学
3区
N/A
WOS期刊SCI分区  2024-2025最新升级版
按JIF指标学科分区收集子录JIF分区JIF排名百分位
学科:ONCOLOGY
SCIE
Q2
91/328
学科:PHARMACOLOGY & PHARMACY
SCIE
Q1
79/352
按JCR指标学科分区收集子录JCR分区JCR排名百分位
学科:ONCOLOGY
SCIE
Q2
136/328
学科:PHARMACOLOGY & PHARMACY
SCIE
Q2
155/353
36
97
23%0约3.0个月-医学-药学
7.3%
时间预警情况
2026年03月发布的新锐学术版不在预警名单中
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
80.41%4.73%-
CiteScore:5.60
SJR:0.667
SNIP:0.683
学科类别分区排名百分位
大类:Medicine
小类:Pharmacology (medical)
Q2
77 / 275
大类:Medicine
小类:Oncology
Q2
131 / 415
大类:Medicine
小类:Drug Discovery
Q2
64 / 156
大类:Medicine
小类:Cancer Research
Q2
107 / 233

期刊高被引文献

Repurposing Disulfiram as an Anti-Cancer Agent: Updated Review on Literature and Patents.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666190514104035
From Antimicrobial to Anticancer Peptides: The Transformation of Peptides.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666190119165157
HMGA and Cancer: A Review on Patent Literatures.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666190919152001
Tobacco Smoking: Risk to Develop Addiction, Chronic Obstructive Pulmonary Disease, and Lung Cancer.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666190102122848
A truncated Snail1 transcription factor alters expression of essential EMT markers and suppresses tumor cell migration in a human lung cancer cell line.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666190527111429
Tocotrienols and Cancer: From the State of the Art to Promising Novel Patents.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666190116111827
New Anti-Cancer Strategies in Testicular Germ Cell Tumors.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666190111120023
Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666190116122256
MDM2-p53 Interaction Inhibitors: Current State of Art and Updated Patent Review (2010-present).
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666191022163540
Contemporary Formulations for Drug Delivery of Anticancer Bioactive Compounds.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666190111104834
Apigenin, A Plant Flavone Playing Noble Roles in Cancer Prevention Via Modulation of Key Cell Signaling Networks.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666191026095728
Enzyme and Transporter Kinetics for CPT-11 (Irinotecan) and SN-38: An Insight on Tumor Tissue Compartment Pharmacokinetics Using PBPK.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666190212164356
Chimeric Antigen Receptor T Cell Immunotherapy for Tumor: A Review of Patent Literatures
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666190111120908
Nanostructured Systems in Advanced Drug Targeting for the Cancer Treatment: Recent Patents.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892813666181031154146
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Lung Cancer.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666190726124735
Chimeric Antigen Receptor-Engineered T-Cells - a New Way and Era for Lymphoma Treatment.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666191022164641
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Advanced Thyroid Cancer.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666190726143011
Mechanism of a Novel Camptothecin-Deoxycholic Acid Derivate Induced Apoptosis Against Human Liver Cancer HepG2 Cells and Human Colon Cancer HCT116 Cells.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666191016162346
Inhibitory effect of hydroxysafflower yellow B on the proliferation of human breast cancer MCF-7 cells.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574891X14666190516102218
Lentiviral-Mediated Beclin-1 Overexpression Inhibits Cell Proliferation and Induces Autophagy of Human Esophageal Carcinoma Eca109 Cell Xenograft in Nude Mice.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666191211130342
Tissue Distribution and Systemic Toxicity Evaluation of Raloxifene Targeted Polymeric Micelles of Poly (Styrene-Maleic Acid)-Poly (Amide-Ether-Ester-Imide)-Poly (Ethylene Glycol) Loaded With Docetaxel in Breast Cancer Bearing Mice.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666190919163731
Association between hTERT Polymorphisms and Female Papillary Thyroid Carcinoma.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666190919145453
Safety Profiles and Pharmacovigilance Considerations for Recently Patented Anticancer Drugs: Cutaneous Melanoma.
来源期刊:Recent patents on anti-cancer drug discoveryDOI:10.2174/1574892814666190726130351

相关文章

2026年3月发布
大类学科小类学科Top期刊综述期刊
医学3区
ONCOLOGY 肿瘤学
3区
PHARMACOLOGY & PHARMACY 药学
3区
N/A
2025年3月升级版
大类学科小类学科Top期刊综述期刊
医学4区
ONCOLOGY 肿瘤学
4区
PHARMACOLOGY & PHARMACY 药学
4区
2023年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学4区
ONCOLOGY 肿瘤学
4区
PHARMACOLOGY & PHARMACY 药学
4区